This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations by Thinle Chodon
Introduction
Thinle Chodon is an accomplished inventor based in Buffalo, NY (US). He has made significant contributions to the field of biotechnology, particularly in the area of cancer treatment. His innovative work focuses on developing methods and materials that enhance the efficacy of stem cell therapies.
Latest Patents
Thinle Chodon holds a patent for a "Codon-optimized lentiviral vector for stem cell reprogramming." This invention relates to methods and materials that can be used to produce cytotoxic T cells targeting cancer cells expressing the cancer-testis antigen NY ESO-1. The illustrative embodiments of this invention include peripheral blood stem cells transduced with a lentiviral vector that comprises codon-optimized TCR alpha and beta chain polypeptides specific for NY ESO-1. These gene-modified cells are particularly useful in hematopoietic stem cell transplantation settings to treat patients diagnosed with NY ESO-1 positive cancers. He has 1 patent to his name.
Career Highlights
Thinle Chodon is affiliated with the University of California, where he continues to advance his research in the field of stem cell therapy and cancer treatment. His work has the potential to significantly impact the lives of patients suffering from specific types of cancer.
Collaborations
Some of his notable coworkers include Richard C Koya and Antoni Ribas, who are also involved in groundbreaking research in the field of oncology and stem cell therapies.
Conclusion
Thinle Chodon is a pioneering inventor whose work in developing innovative therapies for cancer treatment showcases the potential of biotechnology. His contributions are paving the way for new treatment options for patients facing challenging diagnoses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
